Work

A randomized Phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A Cancer and Leukemia Group B study

Year: 1996

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Lung Cancer

DOI: 10.1016/0169-5002(96)00556-9

Authors: Stephen L. Graziano, Frank H. Valone, James E. Herndon, Jeffrey Crawford, Frederick Richards, Vishram B. Rege, Gerald Clamon, Mark R. Green

Institutions: State University of New York, SUNY Upstate Medical University, Dartmouth–Hitchcock Medical Center, Dartmouth Cancer Center, Duke Medical Center, Atrium Health Wake Forest Baptist, Brown University, Rhode Island Hospital, University of Iowa, University of Iowa Hospitals and Clinics, University of California San Diego

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G2647518335, Cancer and Leukemia Group B Statistical Center, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B (CALGB), G866232813, G877907214

OpenAlex ID: W2025027408

FWCI: 1.212

Cites: 36

Cited by: 13

Related to: 10